Skip to main content

Table 1

From: Effects of NRTI backbone on HIV RNA, CD4 counts and lipids for first-line boosted PI-based HAART: meta-analysis of 12 clinical trials in 4,896 patients

NRTI backbone

TDF/FTC

  

ABC/3TC

  

PI

N

RNA<50

95% CI

N

RNA<50

95% CI

LPV/r

2285

74%

72–76%

722

66%

63–70%

fAPV/r

53

75%

63–87%

722

67%

63–70%

ATV/r

493

79%

75–82%

112

77%

68–85%

SQV/r

166

65%

58–72%

no data

-

-

DRV/r

343

84%

80–88%

no data

-

-